Clinical data from the Phase 1/2a clinical trial evaluating RPESC-RPE-4W was presented at the 77th Annual Wills Eye Conference in Philadelphia, Pennsylvania on March 6, 2025. The findings were from 6 ...
Luxa Biotechnology's RPESC-RPE-4W transplantation received FDA's RMAT designation for treating dry AMD, highlighting its potential to address unmet patient needs. RPESC-RPE-4W is derived from adult ...
Hosted on MSN1mon
Chery revamps 2025 Tiggo 7 Pro line-up, adds two new variantsThe Chinese car maker is replacing its previous three-variant SUV line-up in favour of two new Special Editions, cutting the point of entry by $10,000. Chery Australia has replaced the Urban ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback